PMV Pharmaceuticals Ownership 2024 | Who Owns PMV Pharmaceuticals Now?
Institutional Ownership
11.73%
Insider Ownership
2.60%
Retail Ownership
85.67%
Institutional Holders
21.00
PMV Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 12.59% | 0.21% | 6,475,291 | - | - | 10,489,971 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 5.45% | 0.05% | 2,804,782 | -393,974 | -12.32% | 4,543,747 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 5.26% | 1.19% | 2,708,408 | 2,708,408 | 100.00% | 4,387,621 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 5.11% | 0.53% | 2,627,643 | - | - | 4,256,782 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 4.56% | 0.01% | 2,345,361 | - | - | 3,799,484 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.44% | 0.00% | 2,282,090 | -170,021 | -6.93% | 3,696,986 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 4.04% | 0.01% | 2,078,866 | -1,328 | -0.06% | 3,365,000 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 2.55% | 1.51% | 1,309,397 | 2,907 | 0.22% | 2,121,223 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 2.48% | 0.10% | 1,275,462 | - | - | 2,066,248 | Jun 30, 2024 |
| BLACKROCK INC. | 2.26% | - | 1,162,193 | -1,948,116 | -62.63% | 1,882,753 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.98% | 0.00% | 1,019,628 | 298,993 | 41.49% | 1,651,797 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.57% | 0.00% | 808,744 | -286,506 | -26.16% | 1,310,165 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.51% | 0.01% | 779,025 | -47,679 | -5.77% | 1,262,020 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.47% | 0.00% | 758,740 | 103,279 | 15.76% | 1,229,159 | Jun 30, 2024 |
| PERSONAL CFO SOLUTIONS, LLC | 1.07% | 0.14% | 550,342 | - | - | 891,554 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.92% | 0.18% | 475,000 | 3,519 | 0.75% | 769,500 | Jun 30, 2024 |
| BARCLAYS PLC | 0.90% | 0.00% | 464,952 | -28,598 | -5.79% | 753,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.85% | 0.00% | 439,139 | 5,286 | 1.22% | 711,405 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | 0.00% | 427,724 | -475,413 | -52.64% | 693,076 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.75% | 0.00% | 388,308 | -11,402 | -2.85% | 629,059 | Jun 30, 2024 |
PMV Pharmaceuticals's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 12.59% of the company's total share outstanding, currently valued at $10.49M. The top 10 institutional shareholders own together 48.73% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 2.55% | 1.51% | 1,309,397 | 2,907 | 0.22% | 2,121,223 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 5.26% | 1.19% | 2,708,408 | 2,708,408 | 100.00% | 4,387,621 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 5.11% | 0.53% | 2,627,643 | - | - | 4,256,782 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.68% | 0.53% | 351,243 | 351,243 | 100.00% | 569,014 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.70% | 0.51% | 358,400 | 358,400 | 100.00% | 580,608 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.69% | 0.31% | 353,749 | 1,874 | 0.53% | 573,073 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 12.59% | 0.21% | 6,475,291 | - | - | 10,489,971 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.73% | 0.19% | 375,000 | -300,000 | -44.44% | 607,500 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.92% | 0.18% | 475,000 | 3,519 | 0.75% | 769,500 | Jun 30, 2024 |
| PERSONAL CFO SOLUTIONS, LLC | 1.07% | 0.14% | 550,342 | - | - | 891,554 | Jun 30, 2024 |
| EVOKE WEALTH, LLC | 0.12% | 0.12% | 63,233 | 63,233 | 100.00% | 102,438 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 2.48% | 0.10% | 1,275,462 | - | - | 2,066,248 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 5.45% | 0.05% | 2,804,782 | -393,974 | -12.32% | 4,543,747 | Jun 30, 2024 |
| SHAY CAPITAL LLC | 0.32% | 0.04% | 165,400 | -31,778 | -16.12% | 267,948 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.49% | 0.02% | 253,361 | 253,361 | 100.00% | 410,445 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.02% | 62,634 | 62,634 | 100.00% | 101,467 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.29% | 0.02% | 147,542 | -47,464 | -24.34% | 239,018 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.12% | 0.02% | 64,009 | - | - | 103,695 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.10% | 0.02% | 50,000 | 40,000 | 400.00% | 81,000 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.26% | 0.02% | 134,700 | 103,600 | 333.12% | 218,214 | Jun 30, 2024 |
The largest PMV Pharmaceuticals shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 1.31M shares of PMV Pharmaceuticals (PMVP), representing 1.51% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SIO CAPITAL MANAGEMENT, LLC | 5.26% | 1.19% | 2,708,408 | 2,708,408 | 100.00% | 4,387,621 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.70% | 0.51% | 358,400 | 358,400 | 100.00% | 580,608 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.68% | 0.53% | 351,243 | 351,243 | 100.00% | 569,014 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.98% | 0.00% | 1,019,628 | 298,993 | 41.49% | 1,651,797 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.49% | 0.02% | 253,361 | 253,361 | 100.00% | 410,445 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.51% | 0.00% | 260,028 | 189,214 | 267.20% | 421,245 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.26% | 0.02% | 134,700 | 103,600 | 333.12% | 218,214 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.47% | 0.00% | 758,740 | 103,279 | 15.76% | 1,229,159 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.28% | 0.00% | 145,737 | 95,072 | 187.65% | 236,094 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.39% | - | 200,545 | 81,276 | 68.15% | 324,883 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.15% | 0.00% | 76,963 | 76,963 | 100.00% | 124,680 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.14% | 0.00% | 71,701 | 71,701 | 100.00% | 116,156 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.27% | 0.01% | 139,900 | 64,900 | 86.53% | 226,638 | Jun 30, 2024 |
| EVOKE WEALTH, LLC | 0.12% | 0.12% | 63,233 | 63,233 | 100.00% | 102,438 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.02% | 62,634 | 62,634 | 100.00% | 101,467 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.14% | 0.00% | 69,867 | 59,452 | 570.83% | 113,185 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.10% | 0.00% | 51,124 | 51,124 | 100.00% | 82,821 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 43,246 | 43,220 | 166230.77% | 70,059 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.10% | 0.02% | 50,000 | 40,000 | 400.00% | 81,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.15% | 0.01% | 77,743 | 38,106 | 96.14% | 126,000 | Jun 30, 2024 |
As of Jun 30 2024, PMV Pharmaceuticals's largest institutional buyer is SIO CAPITAL MANAGEMENT, LLC. The company purchased 2.71M stocks of PMVP, valued at $4.39M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.26% | - | 1,162,193 | -1,948,116 | -62.63% | 1,882,753 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.66% | - | 340,386 | -1,027,529 | -75.12% | 551,425 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 145,078 | -640,912 | -81.54% | 235,026,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | - | - | - | -566,879 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | 0.00% | 427,724 | -475,413 | -52.64% | 693,076 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 5.45% | 0.05% | 2,804,782 | -393,974 | -12.32% | 4,543,747 | Jun 30, 2024 |
| MORGAN STANLEY | 0.23% | - | 119,237 | -302,591 | -71.73% | 193,163 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.73% | 0.19% | 375,000 | -300,000 | -44.44% | 607,500 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.57% | 0.00% | 808,744 | -286,506 | -26.16% | 1,310,165 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -205,855 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -200,938 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.44% | 0.00% | 2,282,090 | -170,021 | -6.93% | 3,696,986 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -152,959 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.24% | 0.00% | 126,004 | -146,855 | -53.82% | 204,182 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.03% | - | 12,900 | -118,945 | -90.22% | 20,898 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -117,101 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.35% | 0.00% | 178,592 | -87,332 | -32.84% | 289,319 | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -58,249 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -56,852 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.12% | 0.00% | 62,048 | -52,384 | -45.78% | 100,518 | Jun 30, 2024 |
As of Jun 30 2024, PMV Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -1.95M shares of PMVP, valued at $1.88M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SIO CAPITAL MANAGEMENT, LLC | 5.26% | 1.19% | 2,708,408 | 2,708,408 | 100.00% | 4,387,621 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.70% | 0.51% | 358,400 | 358,400 | 100.00% | 580,608 | Jun 30, 2024 |
| ALDEBARAN CAPITAL, LLC | 0.68% | 0.53% | 351,243 | 351,243 | 100.00% | 569,014 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.49% | 0.02% | 253,361 | 253,361 | 100.00% | 410,445 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.15% | 0.00% | 76,963 | 76,963 | 100.00% | 124,680 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.14% | 0.00% | 71,701 | 71,701 | 100.00% | 116,156 | Jun 30, 2024 |
| EVOKE WEALTH, LLC | 0.12% | 0.12% | 63,233 | 63,233 | 100.00% | 102,438 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.12% | 0.02% | 62,634 | 62,634 | 100.00% | 101,467 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.10% | 0.00% | 51,124 | 51,124 | 100.00% | 82,821 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.07% | 0.00% | 35,069 | 35,069 | 100.00% | 56,812 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.06% | 0.00% | 31,749 | 31,749 | 100.00% | 51,433 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 21,151 | 21,151 | 100.00% | 34,265 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 14,545 | 14,545 | 100.00% | 23,563 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.02% | 0.00% | 12,014 | 12,014 | 100.00% | 19,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.02% | 0.00% | 11,873 | 11,873 | 100.00% | 19,234 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | - | 4,711 | 4,711 | 100.00% | 7,631 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 2,077 | 2,077 | 100.00% | 3,365 | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 3,240 | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | 0.00% | 0.00% | 322 | 322 | 100.00% | 1,000 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 65 | 65 | 100.00% | 105 | Jun 30, 2024 |
PMV Pharmaceuticals's largest new institutional shareholder by number of shares is SIO CAPITAL MANAGEMENT, LLC, purchased 2.71M shares, valued at $4.39M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -566,879 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -205,855 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -200,938 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -152,959 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -117,101 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -58,249 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -56,852 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -50,500 | -100.00% | - | Jun 30, 2024 |
| AMUNDI | - | - | - | -26,182 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -20,217 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -18,705 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -15,492 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -14,491 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -14,180 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -14,020 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -11,419 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -11,315 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -5,336 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -4,124 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,772 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,468 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -1,616 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,279 | -100.00% | - | Jun 30, 2024 |
| PRIVATE WEALTH MANAGEMENT GROUP, LLC | - | - | - | -676 | -100.00% | - | Jun 30, 2024 |
| AVION WEALTH | - | - | - | -299 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
PMV Pharmaceuticals's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -0.57M shares, valued at -, as of undefined.
PMV Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| MERIDIAN FUND INC | 0.59% | 1,371,148 | 167,180 | 13.89% | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.27% | 655,744 | -106,040 | -13.92% | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.19% | 36,039 | - | - | Mar 28, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.17% | 348,786 | - | - | Feb 29, 2024 |
| BlackRock Health Sciences Trust II | 0.12% | 305,830 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.11% | 329,949 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.08% | 1,147,095 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 37,924 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 17,490 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.06% | 60,414 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.06% | 1,288 | - | - | Dec 31, 2023 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.05% | 24,940 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 75,000 | -119,900 | -61.52% | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.03% | 67,951 | -4,909 | -6.74% | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.03% | 96,760 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 250,000 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 772,700 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 16,534 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 67,477 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 83,100 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,590 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 23,572 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 25,897 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 9,900 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,064,838 | -523,941 | -20.24% | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 23,641 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 129,095 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 12,708 | - | - | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 31,933 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 754 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 12,323 | - | - | Dec 31, 2023 |
| ALPS ETF Trust | 0.00% | 28,833 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 88,482 | -14,570 | -14.14% | Jan 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 24,416 | -1,084 | -4.25% | Mar 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 377,335 | 50,656 | 15.51% | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 13,156 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 36,376 | 17,858 | 96.44% | Mar 31, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 31,000 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,772 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 207,390 | - | - | Jan 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 1,172,588 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 31,410 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,279 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 723 | - | - | Jan 31, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 32,400 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,331 | -1,436 | -13.34% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 53,985 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 168,769 | -60 | -0.04% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,720 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 78,518 | 8,400 | 11.98% | Mar 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.00% | 19,489 | - | - | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 27,748 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,176 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,020 | -2,862 | -16.95% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 47,499 | 12,157 | 34.40% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 99,150 | 13,792 | 16.16% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 8,851 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 343,953 | -9,219 | -2.61% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 175,520 | 6,525 | 3.86% | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,331 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 79,224 | -32,748 | -29.25% | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 17,627 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,100 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 437 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,922 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,076 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 21,628 | -3,593 | -14.25% | Mar 28, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 13,504 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 157,298 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 122,304 | 127 | 0.10% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 339,032 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 9,352 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,399,317 | -79,659 | -5.39% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 352 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 167,788 | 19,419 | 13.09% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 223,750 | 200,230 | 851.32% | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 2,558,483 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 6,208 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,400 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 5,887 | 1,452 | 32.74% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 136,805 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 174 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 280,445 | -17,392 | -5.84% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 17,966 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,482 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,500 | 2,100 | 87.50% | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,808 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 138,965 | 18,446 | 15.31% | Feb 29, 2024 |
| ProFunds | 0.00% | 318 | -6 | -1.85% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 156 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 5,649 | -2,432 | -30.10% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,975 | 1,195 | 31.61% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 664 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 23 | - | - | Dec 31, 2023 |
| Franklin Alternative Strategies Funds | 0.00% | 9,168 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 38,743 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,301 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 14,315 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 833 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,268 | - | - | Feb 29, 2024 |
PMV Pharmaceuticals's largest mutual fund holder by % of total assets is "MERIDIAN FUND INC", owning 1.37M shares, compromising 0.59% of its total assets.
PMV Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -79.00% |
| 31 Mar, 24 | 100 | -2.91% |
| 31 Dec, 23 | 103 | -8.04% |
| 30 Sep, 23 | 112 | 2.75% |
| 30 Jun, 23 | 109 | -6.03% |
| 31 Mar, 23 | 116 | -3.33% |
| 31 Dec, 22 | 120 | -2.44% |
| 30 Sep, 22 | 123 | 6.96% |
| 30 Jun, 22 | 115 | - |
| 31 Mar, 22 | 115 | 12.75% |
| 31 Dec, 21 | 102 | 12.09% |
| 30 Sep, 21 | 91 | 5.81% |
| 30 Jun, 21 | 86 | 4.88% |
| 31 Mar, 21 | 82 | 12.33% |
| 31 Dec, 20 | 73 | 43.14% |
| 30 Sep, 20 | 51 | - |
As of 30 Jun 24, 21 institutions are holding PMV Pharmaceuticals's shares, representing a decrease of -79.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,034,370 | -85.88% |
| 31 Mar, 24 | 42,741,191 | -8.02% |
| 31 Dec, 23 | 46,466,060 | -14.33% |
| 30 Sep, 23 | 54,236,271 | 4.79% |
| 30 Jun, 23 | 51,759,522 | 0.48% |
| 31 Mar, 23 | 51,513,449 | -5.55% |
| 31 Dec, 22 | 54,540,818 | -6.25% |
| 30 Sep, 22 | 58,173,801 | -4.83% |
| 30 Jun, 22 | 61,123,899 | 10.63% |
| 31 Mar, 22 | 55,249,422 | 16.47% |
| 31 Dec, 21 | 47,437,066 | 7.83% |
| 30 Sep, 21 | 43,990,530 | 4.11% |
| 30 Jun, 21 | 42,255,189 | 5.86% |
| 31 Mar, 21 | 39,916,454 | 4.45% |
| 31 Dec, 20 | 38,214,222 | 22.43% |
| 30 Sep, 20 | 31,212,908 | - |
PMV Pharmaceuticals (PMVP) has 6.03M shares outstanding as of 30 Jun 24, down -85.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.73% | 0.17% |
| 31 Mar, 24 | 83.08% | 0.93% |
| 31 Dec, 23 | 94.74% | 0.68% |
| 30 Sep, 23 | 118.39% | 0.93% |
| 30 Jun, 23 | 113.08% | 0.89% |
| 31 Mar, 23 | 112.54% | 0.78% |
| 31 Dec, 22 | 120.41% | 0.74% |
| 30 Sep, 22 | 127.51% | 0.71% |
| 30 Jun, 22 | 134.13% | 0.91% |
| 31 Mar, 22 | 121.52% | 1.11% |
| 31 Dec, 21 | 104.73% | 1.11% |
| 30 Sep, 21 | 97.12% | 1.10% |
| 30 Jun, 21 | 93.75% | 1.18% |
| 31 Mar, 21 | 89.13% | 1.22% |
| 31 Dec, 20 | 85.33% | 1.76% |
| 30 Sep, 20 | 69.69% | - |
As of 30 Jun 24, PMV Pharmaceuticals is held by 11.73% institutional shareholders, representing a 0.17% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 13 | -74.00% |
| 31 Mar, 24 | 50 | -13.79% |
| 31 Dec, 23 | 58 | 18.37% |
| 30 Sep, 23 | 49 | -15.52% |
| 30 Jun, 23 | 58 | 1.75% |
| 31 Mar, 23 | 57 | 14.00% |
| 31 Dec, 22 | 50 | -25.37% |
| 30 Sep, 22 | 67 | -12.99% |
| 30 Jun, 22 | 77 | 37.50% |
| 31 Mar, 22 | 56 | -12.50% |
| 31 Dec, 21 | 64 | 36.17% |
| 30 Sep, 21 | 47 | -21.67% |
| 30 Jun, 21 | 60 | 25.00% |
| 31 Mar, 21 | 48 | -12.73% |
| 31 Dec, 20 | 55 | 7.84% |
| 30 Sep, 20 | 51 | - |
13 institutional shareholders have increased their position in PMVP stock as of 30 Jun 24 compared to 50 in the previous quarter (a -74.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -76.92% |
| 31 Mar, 24 | 26 | -13.33% |
| 31 Dec, 23 | 30 | -11.76% |
| 30 Sep, 23 | 34 | 17.24% |
| 30 Jun, 23 | 29 | -21.62% |
| 31 Mar, 23 | 37 | - |
| 31 Dec, 22 | 37 | 15.63% |
| 30 Sep, 22 | 32 | 77.78% |
| 30 Jun, 22 | 18 | -37.93% |
| 31 Mar, 22 | 29 | 31.82% |
| 31 Dec, 21 | 22 | -18.52% |
| 30 Sep, 21 | 27 | 92.86% |
| 30 Jun, 21 | 14 | -30.00% |
| 31 Mar, 21 | 20 | 81.82% |
| 31 Dec, 20 | 11 | - |
| 30 Sep, 20 | - | - |
6 institutional shareholders have reduced their position in PMVP stock as of 30 Jun 24 compared to 26 in the previous quarter (a -76.92% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 21 | -79.00% | 6,034,370 | -85.88% | 11.73% | 0.17% | 13 | -74.00% | 6 | -76.92% |
| 31 Mar, 24 | 100 | -2.91% | 42,741,191 | -8.02% | 83.08% | 0.93% | 50 | -13.79% | 26 | -13.33% |
| 31 Dec, 23 | 103 | -8.04% | 46,466,060 | -14.33% | 94.74% | 0.68% | 58 | 18.37% | 30 | -11.76% |
| 30 Sep, 23 | 112 | 2.75% | 54,236,271 | 4.79% | 118.39% | 0.93% | 49 | -15.52% | 34 | 17.24% |
| 30 Jun, 23 | 109 | -6.03% | 51,759,522 | 0.48% | 113.08% | 0.89% | 58 | 1.75% | 29 | -21.62% |
| 31 Mar, 23 | 116 | -3.33% | 51,513,449 | -5.55% | 112.54% | 0.78% | 57 | 14.00% | 37 | - |
| 31 Dec, 22 | 120 | -2.44% | 54,540,818 | -6.25% | 120.41% | 0.74% | 50 | -25.37% | 37 | 15.63% |
| 30 Sep, 22 | 123 | 6.96% | 58,173,801 | -4.83% | 127.51% | 0.71% | 67 | -12.99% | 32 | 77.78% |
| 30 Jun, 22 | 115 | - | 61,123,899 | 10.63% | 134.13% | 0.91% | 77 | 37.50% | 18 | -37.93% |
| 31 Mar, 22 | 115 | 12.75% | 55,249,422 | 16.47% | 121.52% | 1.11% | 56 | -12.50% | 29 | 31.82% |
| 31 Dec, 21 | 102 | 12.09% | 47,437,066 | 7.83% | 104.73% | 1.11% | 64 | 36.17% | 22 | -18.52% |
| 30 Sep, 21 | 91 | 5.81% | 43,990,530 | 4.11% | 97.12% | 1.10% | 47 | -21.67% | 27 | 92.86% |
| 30 Jun, 21 | 86 | 4.88% | 42,255,189 | 5.86% | 93.75% | 1.18% | 60 | 25.00% | 14 | -30.00% |
| 31 Mar, 21 | 82 | 12.33% | 39,916,454 | 4.45% | 89.13% | 1.22% | 48 | -12.73% | 20 | 81.82% |
| 31 Dec, 20 | 73 | 43.14% | 38,214,222 | 22.43% | 85.33% | 1.76% | 55 | 7.84% | 11 | - |
| 30 Sep, 20 | 51 | - | 31,212,908 | - | 69.69% | - | 51 | - | - | - |
PMV Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of PMV Pharmaceuticals's stock was made by Gallagher Carol Giltner on Jun 10 2024, selling 67,500 shares at $1.65 per share (valued at $111.38K).
PMV Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 2 | 2 | 100.00% |
| Q3 2023 | 1 | 4 | 25.00% |
| Q2 2023 | 11 | 1 | 1100.00% |
| Q4 2022 | 2 | 1 | 200.00% |
| Q2 2022 | 5 | 4 | 125.00% |
| Q1 2022 | 6 | 2 | 300.00% |
| Q4 2021 | 2 | 6 | 33.33% |
| Q3 2021 | 15 | 85 | 17.65% |
| Q2 2021 | 26 | 88 | 29.55% |
| Q1 2021 | 4 | 17 | 23.53% |
| Q4 2020 | 3 | 2 | 150.00% |
| Q3 2020 | 48 | 61 | 78.69% |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by PMV Pharmaceuticals's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 72 | - |
| Q2 2021 | - | 74 | - |
| Q1 2021 | - | 15 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 8 | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of PMV Pharmaceuticals's stocks.
PMV Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| VIGL | Vigil Neuroscience, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| RLYB | Rallybio Corporation |
| TRDA | Entrada Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| PHVS | Pharvaris N.V. |
| PEPG | PepGen Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| OPT | Opthea Limited |
| ELYM | Eliem Therapeutics, Inc. |
PMVP Ownership FAQ
Who Owns PMV Pharmaceuticals?
PMV Pharmaceuticals is owned by institutional shareholders (11.73%), insiders (2.60%), and public (85.67%). The largest institutional shareholder of PMV Pharmaceuticals is ORBIMED ADVISORS LLC (12.59% of total shares) and the top mutual fund owner is MERIDIAN FUND INC (0.59% of total shares).
Who are the major institutional shareholders of PMV Pharmaceuticals?
PMV Pharmaceuticals's major institutional shareholders are ORBIMED ADVISORS LLC, ARROWMARK COLORADO HOLDINGS LLC, SIO CAPITAL MANAGEMENT, LLC, EUCLIDEAN CAPITAL LLC, and ALKEON CAPITAL MANAGEMENT LLC. The top five shareholders own together 32.97% of the company's share outstanding.
How many PMV Pharmaceuticals shareholders are there?
As of Jun 2024, there are 21 institutional shareholders of PMV Pharmaceuticals.
What percentage of PMV Pharmaceuticals is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 6.48M shares of PMV Pharmaceuticals, representing 12.59% of the company's total shares outstanding, valued at $10.49M (as of Jun 2024).
What percentage of PMV Pharmaceuticals is owned by ARROWMARK COLORADO HOLDINGS LLC?
As of Jun 2024, ARROWMARK COLORADO HOLDINGS LLC holds 2.8M shares of PMV Pharmaceuticals (PMVP), compromising 5.45% of the company, valued at $4.54M.
What percentage of PMV Pharmaceuticals is owned by SIO CAPITAL MANAGEMENT, LLC?
SIO CAPITAL MANAGEMENT, LLC is the third largest holder of PMV Pharmaceuticals. The company owns 2.71M of the company's shares outstanding (worth $4.39M).